• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FARAPULSE, INC. FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FARAPULSE, INC. FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER Back to Search Results
Lot Number 0032365566
Device Problems Positioning Failure (1158); Difficult to Remove (1528); Detachment of Device or Device Component (2907)
Patient Problem Unspecified Tissue Injury (4559)
Event Date 04/05/2024
Event Type  Injury  
Event Description
It was reported that the patient experienced tissue damage due to difficulty withdrawing the catheter.During a pulse field ablation (pfa) catheter using a farawave pulsed field ablation catheter the patient experienced tissue damage due to difficulty withdrawing the catheter.After ablating and checking the right inferior pulmonary vein (ripv) a malfunction with the deployment slider on the catheter handle occurred and it was not possible to undeploy the catheter and fold the array.It was difficult to withdraw the catheter through the sheath and out of the patient, though eventually the array could be folded using a rotating motion to get it inside the sheath and allow the catheter to be withdrawn.This caused expansion of the transseptal puncture hole and the access site hole in the femoral vein.It was also observed that the catheter array had separated partially from the shaft of the catheter.The procedure was completed since the catheter could be deployed to the basket and flower shapes to ablate the final pulmonary vein, the right superior pulmonary vein (rspv), and the patient was admitted to the hospital for monitoring.The patient stayed at the hospital for two days and was discharged with no further complications observed.The device is expected to be returned for analysis.
 
Manufacturer Narrative
The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM
Type of Device
CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER
Manufacturer (Section D)
FARAPULSE, INC.
3715 haven avenue
suite 110
menlo park CA 94025
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key19177609
MDR Text Key341000841
Report Number2124215-2024-24769
Device Sequence Number1
Product Code QZI
Combination Product (y/n)N
Reporter Country CodePL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Lot Number0032365566
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/05/2024
Initial Date FDA Received04/24/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/07/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-